Table of Contents – The MedTech Strategist, Vol. 4, No. 9, June 16, 2017 (48 Pages; Purchase this Full Issue):
- Connected Health—“Consumerism Drives New Interest in Virtual Care Models but Challenges Persist,” by Mary Thompson
- Venture Capital in China—“Serica: Pioneering a Silk Road in Medtech,” by David Cassak
- Orthopedics—“New CEO Mark Augusti Makes the Case for ConforMIS’ Customized Approach in a Value-Based Environment,” by Wendy Diller
- Clinical Trial Strategies—“Avoiding Common Pitfalls in Clinical Trial Development,” by Vicki Anastasi, ICON plc
- Start-Ups To Watch—“Zipnosis Innovates on Traditional Telemedicine with Data Analytics and Asynchronous Communication Tools,” by Mary Thompson
- Start-Ups To Watch—“MedyMatch: In Stroke, Using Artificial Intelligence to Transform Average Physicians into Experts,” by Mary Stuart
Consumerism Drives New Interest in Virtual Care Models but Challenges Persist
By Mary Thompson
Virtual healthcare, which includes telemedicine and other remote patient monitoring tools, has become something of a buzzword in the digital health arena, and there are clear signs that adoption is on the rise. However, many barriers persist to the routine use of these technologies; chief among them: a continuing lack of adequate reimbursement.
Advanced ICU Care—American Well—Analyte Health Inc.—Doctor on Demand—Johnson & Johnson—LabCorp.—MDLive—Philips Healthcare—PhysIQ—Quest Diagnostics—REACH Health Inc.—Samsung—Teladoc Inc.—Vital Connect Inc.—Vivify Health—WellDoc—Zipnosis
Venture Capital in China
Serica: Pioneering a Silk Road in Medtech
By David Cassak
Serica is one of the latest VC firms established in China to bring novel technologies forward. But while many Chinese investors are focused on opportunities in Western markets, Serica, founded by two seasoned serial entrepreneurs, is looking for technologies to bring back to China. Their investment thesis: that there is an historical opportunity for medtech in China today, not just for devices that are already on the market in the West, but also for emerging technologies coming to the fore.
Eolo—Fosun Pharmaceuticals—GlaxoSmithKline—Intuitive Surgical Inc.—Medtronic plc—Mindray Medical International Ltd.—NeuroVent—Park Medical—Qiagen—Spirosure Inc.—United Medical
New CEO Mark Augusti Makes the Case for ConforMIS’ Customized Approach in a Value-Based Environment
By Wendy Diller
ConforMIS did not introduce new products this year at the American Academy of Orthopaedic Surgeons (AAOS), but it did debut a new CEO, Mark Augusti, who brings a wealth of large-company experiences and fresh ideas to a company that he describes as transitioning from ‘startup’ mode to one with a sustainable growth strategy.
ConforMIS—GE Medical Systems—IntegraLifeSciences—Smith& Nephew plc—Stryker Corp.—Zimmer Biomet
Clinical Trial Strategies
Avoiding Common Pitfalls in Clinical Trial Development
By Vicki Anastasi, ICON plc
The bar for medtech clinical trials keeps getting higher, both in the US and Europe, making the margin for error increasingly costly in terms of time and resources. New tools and approaches like adaptive design and big data can help companies avoid many commonly made mistakes and manage their trials more efficiently.
Start-Ups To Watch
Zipnosis Innovates on Traditional Telemedicine with Data Analytics and Asynchronous Communication Tools
By Mary Thompson
Zipnosis is a software-as-a-service (SaaS) company that has carved out a unique position in the direct-to-consumer (DTC) telemedicine marketplace. The company’s primary aim is to improve the efficiency and ROI associated with virtual care, which it accomplishes in large part by helping providers limit time-consuming live clinician video and phone consultations to cases in which such visits clearly add value.
Start-Ups To Watch
MedyMatch: In Stroke, Using Artificial Intelligence to Transform Average Physicians into Experts
By Mary Stuart
MedyMatch employs deep learning and machine vision to help clinicians in the ER rule out brain bleed in patients who present with stroke symptoms.
IBM Watson Health—MedyMatch Technology Ltd.—Samsung Electronics